id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-010550-lfbjvche	Petran, Jan	Validation of RESP and PRESERVE score for ARDS patients with pumpless extracorporeal lung assist (pECLA)	2020-05-02		.txt	text/plain	3764	202	45	METHODS: In a retrospective single center cohort study we calculated and evaluated RESP, PRESERVE, and SOFA score for 73 ARDS patients with pumpless Extracorporeal Lung Assist treated between 2002 and 2016 using the XENIOS iLA Membrane Ventilator. Specific mortality risk scores, especially the Respiratory ECMO Survival Prediction (RESP) score [1] and the PRedicting dEath for SEvere ARDS on VV-ECMO (PRE-SERVE) score [2] , were developed and validated for ARDS patients with veno-venous high-flow Extracorporeal Membrane Oxygenation (ECMO). RESP and/or PRESERVE scores have been compared and evaluated in several studies for ECMO therapy [10] [11] [12] [13] [14] [15] [16] , but both scores as well as SOFA score have not been validated for ARDS patients treated with a primary extracorporeal CO 2 removal, like pECLA. In this retrospective study we tested the hypothesis that RESP and PRESERVE score are suitable to assume the mortality risk of pECLA therapy in case of ARDS and are superior to the SOFA score, which is not specific for Extracorporeal Lung Support and ARDS.	./cache/cord-010550-lfbjvche.txt	./txt/cord-010550-lfbjvche.txt